{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T04:21:30Z","timestamp":1769314890307,"version":"3.49.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1097\/md.0000000000005993","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T11:47:41Z","timestamp":1488368861000},"page":"e5993","source":"Crossref","is-referenced-by-count":7,"title":["Correlations of CYP2C9*3\/CYP2D6*10\/CYP3A5*3 gene polymorphisms with efficacy of etanercept treatment for patients with ankylosing spondylitis"],"prefix":"10.1097","volume":"96","author":[{"given":"Yuan-Yuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210309","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4329\/wjr.v7.i9.236","article-title":"Ankylosing spondylitis: a state of the art factual backbone","volume":"7","author":"Ghasemi-Rad","year":"2015","journal-title":"World J Radiol"},{"key":"R2-8-20210309","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.2003.011247","article-title":"How to diagnose axial spondyloarthritis early","volume":"63","author":"Rudwaleit","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R3-8-20210309","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/TACG.S37325","article-title":"The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis","volume":"7","author":"Tsui","year":"2014","journal-title":"Appl Clin Genet"},{"key":"R4-8-20210309","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/ar3369","article-title":"Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study","volume":"13","author":"Arends","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R5-8-20210309","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00832008","article-title":"Biological insights from clinical trials with anti-TNF therapy","volume":"20","author":"Feldmann","year":"1998","journal-title":"Springer Semin Immunopathol"},{"key":"R6-8-20210309","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00296-014-3080-5","article-title":"Etanercept biosimilars","volume":"35","author":"Azevedo","year":"2015","journal-title":"Rheumatol Int"},{"key":"R7-8-20210309","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/187152010794474019","article-title":"Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents","volume":"10","author":"Lee","year":"2010","journal-title":"Anticancer Agents Med Chem"},{"key":"R8-8-20210309","first-page":"11","article-title":"Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy","volume":"4","author":"Li","year":"2011","journal-title":"Pharmgenomics Pers Med"},{"key":"R9-8-20210309","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1631\/jzus.B1400282","article-title":"Genetic polymorphisms of CYP2D6*10 and the effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in infertile men with idiopathic oligozoospermia","volume":"16","author":"Tang","year":"2015","journal-title":"J Zhejiang Univ Sci B"},{"key":"R10-8-20210309","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jaci.2015.02.009","article-title":"Effect of CYP3A5*3 on asthma control among children treated with inhaled beclomethasone","volume":"136","author":"Stockmann","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R11-8-20210309","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.patbio.2012.10.002","article-title":"Effect of different genetics variants: CYP2C9*2, CYP2C9*3 of cytochrome P-450 CYP2C9 and 1639G>A of the VKORC1 gene; on acenocoumarol requirement in Moroccan patients","volume":"61","author":"Smires","year":"2013","journal-title":"Pathol Biol (Paris"},{"key":"R12-8-20210309","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2015.12.062","article-title":"The roles of apolipoprotein E3 and CYP2D6 (rs1065852) gene polymorphisms in the predictability of responses to individualized therapy with donepezil in Han Chinese patients with Alzheimer's disease","volume":"614","author":"Lu","year":"2016","journal-title":"Neurosci Lett"},{"key":"R13-8-20210309","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2350-15-76","article-title":"Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs","volume":"15","author":"Berno","year":"2014","journal-title":"BMC Med Genet"},{"key":"R14-8-20210309","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1292\/jvms.11-0036","article-title":"Downregulation of hepatic cytochrome P450 3A in mice infected with Babesia microti","volume":"74","author":"Shimamoto","year":"2012","journal-title":"J Vet Med Sci"},{"key":"R15-8-20210309","first-page":"56","article-title":"World Medical Association publishes the Revised Declaration of Helsinki.","volume":"27","year":"2014","journal-title":"Natl Med J India"},{"key":"R16-8-20210309","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.38.1.389","article-title":"In vitro and in vivo drug interactions involving human CYP3A","volume":"38","author":"Thummel","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R17-8-20210309","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s10067-014-2710-3","article-title":"Cytochrome P450 interactions and clinical implication in rheumatology","volume":"33","author":"Cayot","year":"2014","journal-title":"Clin Rheumatol"},{"key":"R18-8-20210309","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/bcp.12760","article-title":"Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis","volume":"81","author":"Hopkins","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"R19-8-20210309","first-page":"426","article-title":"Genetic polymorphisms in metabolic pathways of leflunomide in the treatment of rheumatoid arthritis","volume":"33","author":"Soukup","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"R20-8-20210309","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3892\/ijmm.2014.1844","article-title":"A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-alpha activity","volume":"34","author":"Liu","year":"2014","journal-title":"Int J Mol Med"},{"key":"R21-8-20210309","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3892\/ijmm.2013.1435","article-title":"EETs and CYP2J2 inhibit TNF-alpha-induced apoptosis in pulmonary artery endothelial cells and TGF-beta1-induced migration in pulmonary artery smooth muscle cells","volume":"32","author":"Feng","year":"2013","journal-title":"Int J Mol Med"},{"key":"R22-8-20210309","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0","article-title":"A genome-wide screen for susceptibility loci in ankylosing spondylitis","volume":"41","author":"Brown","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R23-8-20210309","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/hmg\/9.11.1563","article-title":"Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis","volume":"9","author":"Brown","year":"2000","journal-title":"Hum Mol Genet"},{"key":"R24-8-20210309","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/09546634.2013.825041","article-title":"An update on drug\u2013drug interactions with biologics for the treatment of moderate-to-severe psoriasis","volume":"25","author":"Gupta","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"R25-8-20210309","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.GIM.0000153664.65759.CF","article-title":"CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis","volume":"7","author":"Sanderson","year":"2005","journal-title":"Genet Med"},{"key":"R26-8-20210309","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/bcr1640","article-title":"Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer","volume":"9","author":"Wegman","year":"2007","journal-title":"Breast Cancer Res"},{"key":"R27-8-20210309","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1742-7843.2008.00327.x","article-title":"Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients","volume":"103","author":"Quteineh","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R28-8-20210309","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/art.23092","article-title":"Influence of -308A\/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis","volume":"57","author":"Guis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R29-8-20210309","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1517\/17425255.2014.970165","article-title":"Pharmacogenetics of etanercept: role of TNF-alpha gene polymorphisms in improving its efficacy","volume":"10","author":"Murdaca","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:42:44Z","timestamp":1620960164000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201703030-00008"}},"subtitle":["A case\u2013control study"],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005993","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}